SAI - Detailed view

OVIXAN Creme 1 mg/g Tb 30 g

Drug

Name

Ovixan, Crème

Field of application

kortikoidempfindliche, nichtinfektiöse Dermatosen, chronische Dermatosen wie Psoriasis und atopische Dermatitis (Neurodermatitis)

ATC

D07AC13 - MOMETASONE

10.05.1. – simple corticosteroids

Use

HAM – Human medicine

pharmaceutical form

CREM – Cream

Remedy code

S – synthetic products for human use

Dispensing categories

B – Dispensed on prescription by a physician or veterinarian (B)

Authorisation status

Z – approved

Authorisation number

65525

Initial registration date

10/27/2015

Expiry date

12/31/9999

Dosage strength

Name

Ovixan 1 mg/g, Crème

Field of application

kortikoidempfindliche, nichtinfektiöse Dermatosen, chronische Dermatosen wie Psoriasis und atopische Dermatitis (Neurodermatitis)

Dosage strength number

Authorisation status

Z – approved

Package

GTIN**

7680655250017

Trade status*

In trade from / since 10/27/2015

Status

A/R – Authorised / referenced

Package size

30 g

Package code

001

Authorisation status

Z – approved

Declaration

Component

Active substance

1 mg mometasoni furoas
0.82 mg mometasonum

Excipient

cocois oleum
70 mg alcohol cetylicus et stearylicus
acidum stearicum
macrogoli stearas
glyceroli monostearas 40-55
250 mg propylenglycolum
aqua purificata
natrii citras dihydricus
acidum citricum

Spezialitätenliste***

Status

Date of deletion

Compulsory until

Public price (CHF)

14.60

Limitation points

None

Limitation

SB Deductible

10%

Generic

Authorisation holder

GLN**

7612053000000

Address

Gebro Pharma AG
Grienmatt 2
4410 Liestal (BL)

Date of revision of the text

4/29/2025

Information for prof.

Leaflet

Report error

Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.